Prevalence of Cryptosporidium sp in equids in Louisiana

In 1985, 22 pony foals reared in a helminth-free environment were tested daily for oocysts of Cryptosporidium sp by use of fecal flotation. Oocysts were found in all foals. Oocysts were first observed in feces collected from foals 9 to 28 days after birth. The mean period of oocyst shedding was 10 days and ranged from 2 to 18 days in individual foals. Diarrhea was observed in 14 of 22 (64%) foals and began before the period of oocyst shedding. Fecal samples also were examined for other infective agents. Salmonella poona was isolated from 1 foal that did not have diarrhea, and coronavirus particles were observed in the feces of 2 foals with diarrhea. Cryptosporidium sp oocysts also were observed in feces of 2 of 17 Thoroughbred foals, 3 of 14 Quarter Horse foals, and 3 of 26 pony foals reared on pastures with their dams. Samples from pasture-reared foals were collected at irregular intervals. Of the 11 Cryptosporidium-positive fecal samples collected from pastured foals, 2 were from foals with diarrhea. A similar survey was conducted during the 1986 foaling season, using the same procedures. Examination of 300 samples from 58 Quarter Horse, Arabian, and pony foals did not detect oocysts. Daily examination of feces from 10 pony foals reared under helminth-free conditions for 30 days also failed to detect Cryptosporidium oocysts.     

Prevalence and spatial distribution of bovine tuberculosis in brushtail possums on a forest-scrub margin

Tuberculosis caused by Mycobacterium bovis was diagnosed in 36 of 68 (53%) brushtail possums (Trichosurus vulpecula) trapped in August 1992 from a population of exceptionally low density (trap catch <3%) on a forest-scrub margin in Westland, New Zealand. The prevalence of tuberculosis in possums, based solely on gross lesions, was at least twice that previously recorded in New Zealand, and was about seven times that recorded from the same population in 1980. More male (66%) than female (33%) possums had grossly visible tuberculous lesions. The distribution of infection appeared continuous along the forest-scrub margin. Both stoats (Mustela erminea) and one of six hares (Lepus europaeus occidentalis) trapped were also infected with M. bovis.     

A pulmonary granular cell tumour with associated hypertrophic osteopathy in a horse

Abstract Extract A 15-year-old pony mare developed firm irregular bony swellings on all four legs. These were most severe around the carpal and fetlock joints of the forelegs, restricting both flexion and extension. Over about 6 months the horse had periodic bouts of coughing. She showed moderate weight loss and a depressed demeanour.     

Antimicrobial substances and chick growth promotion: The growth‐promoting activities of antimicrobial substances,including fifty‐two used either in therapy or as dietary additives

1. Fifty‐five antimicrobial substances were tested for their ability to promote growth when added to the diet of chicks.

2. Both cephalosporins and all the nine penicillins tested were active.

3. Of six aminoglycosides, streptomycin and gentamicin had the greatest activity and neomycin had none.

4. Growth rate was significantly improved by clindamycin, lincomycin, vancomycin, spectinomycin, rifampicin, oxytetracycline, chlortetracycline, erythromycin, tylosin, flavomycin, virginiamycin and zinc bacitracin. Chloramphenicol and nalidixic acid were inactive. Polymixin B, novo‐biocin, cycloserine, phosphonomycin, and sodium fusidate had little activity. Fusidic acid promoted growth at 250 mg/kg diet.

5. Trimethoprim was inactive alone and in combination with sulpha‐diazine. Of seven 5‐nitroimidazoles, only dimetridazole and metronidazole showed slight activity. Of the six 5‐nitrofurans, only nitrovin, the standard reference substance used, promoted growth.

6. Caprylohydroxamic acid, a urease inhibitor, had no beneficial effect on growth rate or on the efficiency of food conversion.

7. The growth‐promoting properties of the various substances could not be related with their known antimicrobial and absorption characteristics in mammals.     

Antimicrobial substances and chick growth promotion: Comparative studies on selected compounds in vitro and in vivo

1. Antibacterial activity of selected compounds in vitro and their ability to promote growth when added to the diet of chicks were not correlated.

2. The difference in growth‐promoting activity between streptomycin, which was active, and kanamycin which was not, was not related to their effects on the flora adhering to the wall of the crop, jejunum or ileum, to their relative toxicity to the chick nor to differences in their stability in the diet.

3. When low concentrations ofkanamycin or streptomycin were given, the antibiotic was concentrated in the caecal contents. In contrast, penicillin was undetectable in the caeca of birds given high concentrations of benzyl penicillin.

4. In chicks given benzyl penicillin, the numbers of Streptococcus faecium increased at the expense of Strep, faecalis. This probably resulted from changes in the crop flora.

5. Birds given high dietary concentrations of benzyl penicillin showed improved weight gains, in spite of increased numbers of Escherichia coli in the small intestine.     

Recovery of brodifacoum in vomitus following induction of emesis in dogs that had ingested rodenticide bait

AIM: To assess the benefit of inducing emesis in dogs that have ingested rodenticide bait containing brodifacoum (BDF), by determining the amount of BDF in bait recovered from the vomitus relative to the estimated amount consumed.

METHODS: Between 2014 and 2015 samples of vomitus from seven dogs that ingested rodenticide baits containing BDF were submitted by veterinarians in New Zealand. All seven dogs had been given apomorphine by the veterinarian and vomited within 1 hour of ingesting the bait. Some or all of the bait particles were retrieved from each sample and were analysed for concentrations of BDF using HPLC. Based on estimations of the mass of bait consumed, the concentration of BDF stated on the product label, and the estimated mass of bait in the vomitus of each dog, the amount of BDF in the vomited bait was calculated as a percentage of the amount ingested.

RESULTS: For five dogs an estimation of the mass of bait ingested was provided by the submitting veterinarian. For these dogs the estimated percentage of BDF in the bait retrieved from the vomitus was between 10–77%. All dogs were well after discharge but only one dog returned for further testing. This dog had a normal prothrombin time 3 days after ingestion.

CONCLUSIONS AND CLINICAL RELEVANCE: The induction of emesis within 1 hour of ingestion can be a useful tool in reducing the exposure of dogs to a toxic dose of BDF. The BDF was not fully absorbed within 1 hour of ingestion suggesting that the early induction of emesis can remove bait containing BDF before it can be fully absorbed.     

Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs

Zoledronate is a bisphosphonate frequently used for the treatment of hypercalcaemia of malignancy and tumour-associated bone pain in dogs, however, there is a paucity of information regarding its use in veterinary medicine. The aim of this retrospective study was to report the tolerability of zoledronate in the palliative treatment of cancer-bearing dogs and secondarily to to assess the efficacy of zoledronate for the treatment of hypercalcaemia of malignancy. Thirty-seven dogs (22 with tumour-associated bone pain and 15 with hypercalcaemia of malignancy) that received 114 zoledronate infusions were included. Tolerability was assessed by the absence of post-zoledronate hypocalcaemia or other adverse events as defined by Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events criteria. Efficacy was assessed by comparison of available ionized calcium levels before and after zoledronate administration in hypercalcaemic dogs. In 79% of zoledronate infusions, no adverse events were reported. The majority of adverse events which occurred in the other 21% of infusions could be attributed to concurrent chemotherapy or the underlying neoplastic disease. There was a small but significant increase in creatinine following treatment with zoledronate, however, none of the dogs developed clinically significant renal disease. In eight hypercalcaemic dogs with available ionized calcium following zoledronate administration, ionized calcium decreased rapidly within 7 days following treatment with zoledronate. Zoledronate is well-tolerated with few recorded adverse events, however, monitoring of serum creatinine is advised. Zoledronate seems to be effective in the treatment of hypercalcaemia of malignancy.